Aritavi
Actavis is pleased to inform you about the launch of Aritavi 30mg and 60mg hard gastro-resistant capsules. Aritavi contains duloxetine. Duloxetine is classified as an SNRI anti-depressant. Indication Starting Dose Maintenance dose Maximum dose Duration of treatment Major depressive Disorder 60mg od 60mg od…
Seroxat
Different indications require different dosage regimens. Please refer to the full SPC for more prescribing information. Succinct Safety Information3 Important Information for Seroxat® Contraindications: Known hypersensitivity to paroxetine, Combination use with monoamine oxidase (MAO) inhibitors (including linezolid, methylene…
Relief – Effective Muscle Relaxant
Cherubino Ltd. is pleased to inform you that we have just launched Relief® Muscle Relaxant. Relief® contains the centrally acting muscle relaxant Thiocolchicoside and is available in 3 different presentations to suit all your patients’ needs: Capsules 4mg Gel 0.25% IM Vials 4mg Relief® is indicated for the adjuvant treatment of painful muscle contractures…
Malarone
Wellbutrin XR
There appears to be a pattern of symptoms that are inadequately addressed by serotonergic antidepressants – loss of pleasure, loss of interest, fatigue and loss of energy1 Evidence suggests that symptoms of decreased positive affect might be mediated by the dysregulation in noradrenergic and dopaminergic…
Victoza® launched in Malta
23rd May 2016 Dear Doctor, Novo Nordisk is pleased to announce the availability of Victoza® ( Liraglutide) in Malta. Victoza® is indicated for treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose-lowering medicinal products and/or basal insulin…